|
|
|
|
Artificial Chromosomes - Study data from K. Dula and colleagues update understanding of artificial chromosomes
Learn more about a six-week, no-risk free trial of Virus Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Artificial Chromosomes Study data from K. Dula and colleagues...
|
|
|
The Wonderful World of Transgenic Animals
Since Dolly the sheep was cloned back in July of 1996, the world of manipulating animal DNA has come a long way.In Massachusetts, goats now produce milk with drugs embedded. There are monkeys whose DNA glows green to enable...
|
|
|
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
- Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including...
|
|
|
Could Stem Cells Patch Up a Broken Heart?
Scientists have identified the master stem cell that gives rise to the three types of heart cells, possibly opening the door for new methods of pharmaceutical research and heart therapies, such as growing a patch to repair cardiac tissue...
|
|
|
Researchers genetically improves castor-oil plants to produce new bio-lubricants
So far, scientists of the University of Almeria have identified and donated a series of genes that are responsible of the biosynthesis of lipids that can be used to obtain transgenic castor-oil plants with an acid profile appropriate for the...
|
|
|
The Wonderful World of Transgenic Animals
animals are proliferatingin the lab.David Biello reports Listen to this podcast: click to enable via: More All [Below is the original script. But a few changes may have been made during the recording of this audio podcast.] Since Dolly...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON , July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/pauljanssenaward/38987/ 'Dr.Ullrich was chosen for his pioneering work in...
|
|
|
2009 Dr. Paul Janssen Award For Biomedical Research Won By Axel Ullrich
Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Contact: Seema Kumar, Johnson & Johnson Pharmaceutical Services, L.L.C London, 1 July, 2009 Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Mission: Gaps no more
CAMBRIDGE, Mass.-While the has done a great deal to advance genomics, and many up-and-coming technologies present the possibility of relatively affordable whole-genome sequencing in the near future, things still aren't perfect, as evidenced...
|
|
|
Ark commences contract manufacture forLx Therapies VEGF-C gene medicine programme
- Ark Therapeutics Group plc ('Ark' or the 'Company') announces today that it has signed an agreement with the private Finnish biotechnology company, Oy Lx Therapies Ltd ('Lx Therapies'), to produce Vascular Endothelial Growth Factor C in an...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Axel Ullrich, Herceptin pioneer, wins Dr. Paul Janssen Award for Biomedical Research
Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including...
|
|
|
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Ark Therapeutics Commences Contract Manufacture For Oy Lx Therapies Ltd VEGF-C Gene Medicine Programme
- Ark Therapeutics Group plc (Ark or the Company) announces today that it has signed an agreement with the private Finnish biotechnology company, (Lx Therapies), to produce Vascular Endothelial Growth Factor C in an Adenoviral Vector (Ad...
|
|
|
::: Ark commences contract manufacture for Lx Therapies VEGF-C gene medicine programme
- Ark Therapeutics Group plc ('Ark' or the 'Company') announces today that it has signed an agreement with the private Finnish biotechnology company, Oy Lx Therapies Ltd ('Lx Therapies'), to produce Vascular Endothelial Growth Factor C in an...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/pauljanssenaward/38987/ 'Dr.Ullrich was chosen for his pioneering work in applying molecular biology and molecular cloning to the discovery of protein...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich , Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
|
|
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel...
|
